Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
Chung
Albert K K
AK
Chua
Siew-eng
SE
D000208:Acute Disease; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000188:drug therapy; D016903:Drug Monitoring; D004565:Electroconvulsive Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D044348:Receptors, Serotonin, 5-HT2 / Q000187:drug effects / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy; D012702:Serotonin Antagonists / Q000009:adverse effects*; D050486:Serotonin Plasma Membrane Transport Proteins / Q000187:drug effects / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*; D014546:Urinary Catheterization; D016055:Urinary Retention / Q000139:chemically induced*
D014150:Antipsychotic Agents; D010879:Piperazines; D044348:Receptors, Serotonin, 5-HT2; D012702:Serotonin Antagonists; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; D013844:Thiazoles; C092292:ziprasidone